Anjaparavanda P. Naren, PhD
- Thomas Boat Chair in Cystic Fibrosis Research, Division of Pulmonary Medicine, Research
- Director, Cystic Fibrosis Research Center, Division of Pulmonary Medicine, Research
- Professor, UC Department of Pediatrics
About
Biography
Cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-regulated chloride channel located primarily on the apical surface of epithelial cells that line various organs, including the airways and the gut. CFTR dysfunction is detrimental and may result in life-threatening medical disorders. Dr. Naren's laboratory studies two such disorders; (1) Cystic fibrosis, a lethal genetic disease that affects mostly the Caucasian population (>30,000 in USA), in which the CFTR chloride channel is HYPO-functional and (2) Secretory diarrhea, a disease affecting millions of children worldwide, in which HYPER-function of the CFTR chloride channel can occur due to infectious toxins, such as cholera toxin and E. coli enterotoxin. His lab is interested in identifying interactions between CFTR and its binding partners and defining how spatiotemporal regulation of CFTR-containing macromolecular complexes in the apical compartment of polarized epithelial cells lining the secretory epithelia regulates overall fluid secretion. Our studies will identify new drug targets for cystic fibrosis, secretory diarrhea, and other diseases resulting from CFTR dysfunction and provide insights into the etiology of diseases associated with CFTR-interacting molecules.
Services and Specialties
Cystic Fibrosis Center
Interests
Cystic fibrosis; secretory diarrhea.
Research Areas
Pulmonary Medicine
Publications
High frequency of germline variants in CFTR identified in PDAC patients enrolled in an expanded panel multi-gene panel testing program. HPB. 2024; 26:1082-1085.
Distinct positions of genetic and oral histories: Perspectives from India. Human Genetics and Genomics Advances. 2024; 5:100305.
Pulmonary Vascular Dysfunctions in Cystic Fibrosis. Physiology (Bethesda, Md.). 2024; 39:0.
Functional Consequences of CFTR Interactions in Cystic Fibrosis. International Journal of Molecular Sciences. 2024; 25.
ABCC4 impacts megakaryopoiesis and protects megakaryocytes against 6-mercaptopurine induced cytotoxicity. Drug Resistance Updates. 2024; 72:101017.
A personalized medicine approach to optimize care for a pediatric cystic fibrosis patient with atypical clinical symptoms. Pediatric Pulmonology. 2024; 59:229-232.
Guided construction of single cell reference for human and mouse lung. Nature Communications. 2023; 14:4566.
Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases: Workshop Proceedings. Diabetes. 2023; 72:433-448.
Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases: Workshop Proceedings. Pancreas. 2022; 51:1061-1073.
Is There a Benefit From Islet Autotransplantation in Patients With Type 1 Diabetes Mellitus Undergoing Total Pancreatectomy?. Pancreas. 2022; 51:399-403.
From the Blog
Pancreas-On-A-Chip May Advance Cystic Fibrosis Research
Anjaparavanda P. "AP" Naren, PhD8/12/2019
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2024 Cincinnati Children's Hospital Medical Center. All rights reserved.
